Metabolism of 1-nitro[U-4,5,9,10-14C]pyrene in the F344 rat.

1-Nitro[U-4,5,9,10-14C]pyrene was synthesized and administered to male F344 rats by intragastric gavage at a dose of 100 mg/kg of body weight. During the first 48 hr, 41% of the dose was eliminated in the feces, and 16% was eliminated in the urine. The corresponding figures after 120 hr were 51 and 19%. In rats with bile cannulae, 37% of the dose was excreted in the bile after 72 hr, and 6% was excreted in the urine. Fecal metabolites included 1-aminopyrene (isolated amount, 11.7% of the dose), 1-amino-6-hydroxypyrene and 1-amino-8-hydroxypyrene (4.6%), and unchanged 1-nitropyrene (6.6%). 1-Aminopyrene and the 1-aminohydroxypyrenes were identified as their acetyl-derivatives by comparison of their chromatographic retention times, mass spectra, and UV spectra to those of synthetic standards. Biliary metabolites included 1-aminopyrene, 1-amino-6-hydroxypyrene, 1-amino-8-hydroxypyrene, 1-nitro-6(8)-hydroxypyrene, and 1-nitro-3-hydroxypyrene, as well as their glucuronide and sulfate conjugates. The isolated amounts of these metabolites accounted for approximately 5% of the dose. 1-Amino-6-hydroxypyrene and 1-amino-8-hydroxypyrene and their glucuronide and sulfate conjugates were also tentatively identified in the urine and accounted for about 3% of the dose. Significant quantities of unidentified water soluble metabolites were present in the urine and bile. The results of this study indicate that metabolic reduction of the highly mutagenic 1-nitrohydroxypyrenes occurs in vivo in the rat and suggest that this is a possible activation pathway in 1-nitropyrene carcinogenesis.

[1]  S. Hecht,et al.  The role of intestinal microflora in the metabolic reduction of 1-nitropyrene to 1-aminopyrene in conventional and germfree rats and in humans. , 1983, Cancer letters.

[2]  F. Beland,et al.  Formation of DNA adducts in vitro and in Salmonella typhimurium upon metabolic reduction of the environmental mutagen 1-nitropyrene. , 1983, Cancer research.

[3]  J. Pitts.  Formation and fate of gaseous and particulate mutagens and carcinogens in real and simulated atmospheres. , 1983, Environmental health perspectives.

[4]  A. Li,et al.  Acute and genetic toxicity of 1-nitropyrene and its fate after single oral doses to rats. , 1982, Journal of toxicology and environmental health.

[5]  S. Hecht,et al.  Comparative tumor initiating activity on mouse skin of 6-nitrobenzo[a]pyrene, 6-nitrochrysene, 3-nitroperylene, 1-nitropyrene and their parent hydrocarbons. , 1982, Cancer letters.

[6]  H. Rosenkranz.  Direct-acting mutagens in diesel exhausts: magnitude of the problem. , 1982, Mutation research.

[7]  J. Pitts,et al.  Mutagens in diesel exhaust particulate. Identification and direct activities of 6-nitrobenzo[a]pyrene, 9-nitroanthracene, 1-nitropyrene and 5h-phenanthro[4,5-bcd]pyran-5-one. , 1982, Mutation research.

[8]  C. E. Voogd.  On the mutagenicity of nitroimidazoles. , 1981, Mutation research.

[9]  G. Mulder,et al.  Alteration of urinary levels of the carcinogen, N-hydroxy-2-naphthylamine, and its N-glucuronide in the rat by control of urinary pH, inhibition of metabolic sulfation, and changes in biliary excretion. , 1981, Chemico-biological interactions.

[10]  G. Smith,et al.  Ligandin, the glutathione S-transferases, and chemically induced hepatocarcinogenesis: a review. , 1977, Cancer research.

[11]  H. Shine,et al.  Ion radicals. XX. Aromatic nitration. New preparation of 3-nitroperylene and 1-nitropyrene , 1971 .

[12]  E. Boyland,et al.  Metabolism of polycyclic compounds. 23. The metabolism of pyrene in rats and rabbits. , 1964, The Biochemical journal.